HYDRA

Medical devices, namely, protein sheaths, namely, linings, coatings, sleeves, time release delivery mechanisms and biodegradable thread or thread-like materials of protein, including peptides, protein enhanced sheaths, namely protein enhanced linings, coatings, sleeves, time release delivery mechanisms and biodegradable thread or thread-like materials, pharmaceutical enhanced sheaths, namely, pharmaceutical enhanced linings, coatings, sleeves, time release delivery mechanisms and biodegradable thread or thread-like materials and stents with protein, protein enhanced or pharmaceutical enhanced sheaths, linings and coatings for use in regenerating and remodeling diseased blood vessels or blocking unwanted regeneration